Teva Bashes Buyers' Expert In Bid To Uphold Antitrust Win

Law360, New York (March 21, 2014, 12:11 PM EDT) -- Teva Pharmaceutical Industries Ltd. on Thursday urged a Massachusetts federal judge to uphold its win in a pay-for-delay class action involving the heartburn drug Nexium, asserting that the direct purchaser class plaintiffs' expert witness had not presented any solid evidence of illicit payment or reasonable damages.

The generic-drug maker said the plaintiffs' efforts to get reconsideration of U.S. District Judge William G. Young's Feb. 12 summary judgment decision are misguided, arguing that expert Dr. Thomas McGuire's estimates about the impact of a 2010 settlement between Teva...
To view the full article, register now.